Evidence by reactivity with hybridoma antibodies for a probable myeloid origin of peripheral blood cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity

The Journal of Clinical Investigation
H D Kay, D A Horwitz

Abstract

Lymphocytes with Fc receptors (FcR) for IgG active in natural cytotoxicity and antibody-dependent cellular cytotoxicity were separated into sheep erythrocyte rosetting (E+) and nonrosetting (E-) fractions, and examined for reactivity with the OK panel of hybridoma-produced monoclonal antibodies. Few cells in either the E+ FcR+ or the E- FcR+ fraction reacted with seven antibodies used to define T cells in various stages of differentiation (OK3, OKT4, OKT5, OKT6, OKT8, OKT9, OKT10). Neither fraction expressed an Ia-like antigen (detected by OKI1), but both were highly reactive with OKM1, an antibody that reacts with monocytes and granulocytes. Incubation of these cytotoxic effector cells with OKM1 plus complement abolished all cytotoxic reactivity, but incubation with a pan-T cell antibody (OKT3) plus complement had no significant effect. These cells were not monocyte precursors, because they could not be induced in vitro to develop macrophage characteristics. The data indicate that most cytotoxic effector cells in natural cytotoxicity and antibody-dependent cellular cytotoxicity are not in the T cell lineage, but have a myeloid origin.

References

Dec 1, 1975·The Journal of Clinical Investigation·D A Horwitz, P I Lobo
Jan 1, 1973·Transplantation Reviews·S S Froland, J B Natvig
Apr 1, 1980·The Journal of Experimental Medicine·E L ReinherzS F Schlossman
Apr 1, 1980·Cell·E L Reinherz, S F Schlossman

❮ Previous
Next ❯

Citations

Jan 1, 1983·Cancer Metastasis Reviews·R K Oldham
Oct 1, 1983·Journal of Clinical Immunology·F S LiglerT J Linna
Jan 1, 1982·Cellular Immunology·C J FroelichN L Warner
Dec 14, 1984·Journal of Immunological Methods·G C ManaraR Scandroglio
Jun 3, 1982·The New England Journal of Medicine·R J van de GriendR S Weening
Dec 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·G F BurnsI R Mackay
Mar 1, 1981·The Journal of Experimental Medicine·T TimonenR B Herberman
Jan 1, 1983·The Journal of Experimental Medicine·T AboC M Balch
Apr 1, 1990·The Journal of Experimental Medicine·J W Young, R M Steinman
Jan 1, 1983·Journal of Clinical Immunology·M FerrariniC E Grossi
Jan 1, 1993·Developmental and Comparative Immunology·N E Herrera-Gonzalez, D W Dresser
Jul 1, 1983·Human Immunology·C BrovallB Schacter
Jan 1, 1981·Immunological Reviews·W J Pichler, S Broder
Jun 1, 1984·Scandinavian Journal of Immunology·B WåhlinH J Müller-Eberhard
Jul 25, 2019·Frontiers in Neurology·Una AvdicChristine T Ekdahl
Oct 15, 1981·International Journal of Cancer. Journal International Du Cancer·P K PattengaleH Wigzell
Jun 1, 1982·European Journal of Immunology·A AstaldiJ M Vossen
Dec 1, 1981·European Journal of Immunology·J LohmeyerG Riethmüller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.